252P Real-world progression-free survival (rwPFS) and time to next line of therapy (TTNT) as intermediate endpoints for survival in metastatic breast cancer: A real-world experience. - Labaki, C.; Bakouny, Z.; Sanglier, T.; Schmidt, A.; Shim, J.; Braun, D.A.; Bouquet, F.; Joyce, M.; Xie, W.; Tolaney, S.M.; Choueiri, T.K. (Annals of Oncology, 2022)